
97.88 Delayed Data As of Nov 30 | ![]() Today’s Change | 75.68 Today|||52-Week Range 99.94 | +14.02% Year-to-Date |
Why Is Pfizer (PFE) Down 1.4% Since Last Earnings Report? Nov 30 / Zacks.com - Paid Partner Content | Olema Pharmaceuticals (OLMA) Skyrockets 471% YTD: Here's Why Nov 27 / Zacks.com - Paid Partner Content |
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies Nov 29 / Zacks.com - Paid Partner Content | Mesoblast (MESO) Up on Deal With BMT CTN to Develop GVHD Drug Nov 23 / Zacks.com - Paid Partner Content |
Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy Nov 28 / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance Health and Vertex Pharmaceuticals Nov 21 / Zacks.com - Paid Partner Content |
3 Large Drug Stocks That Have Outperformed Industry YTD Nov 28 / Zacks.com - Paid Partner Content | Top Stock Reports for Procter & Gamble, Novartis & Mondelez International Nov 20 / Zacks.com - Paid Partner Content |
Previous close | 97.01 |
Today’s open | 96.87 |
Day’s range | 96.73 - 97.91 |
Volume | 1,099,539 |
Average volume (3 months) | 1,319,129 |
Market cap | $201.7B |
Earnings growth (last year) | -70.23% |
Earnings growth (this year) | +17.64% |
Earnings growth (next 5 years) | +11.08% |
Revenue growth (last year) | -2.09% |
P/E ratio | 25.4 |
Price/Sales | 3.94 |
Price/Book | 3.51 |
Today’s change | Today’s % change | |
---|---|---|
AZNAstraZeneca | +0.44 | +0.69% |
PFEPfizer | +0.36 | +1.20% |
ABBVAbbVie | +3.86 | +2.79% |
MRKMerck | +1.32 | +1.31% |
Next reporting date | January 31, 2024 |
EPS forecast (this quarter) | $1.67 |
Annual revenue (last year) | $50.5B |
Annual profit (last year) | $7.0B |
Net profit margin | 13.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |